These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 17575687)
1. [Anti-tumor effects induced by fusion of interleukin-18 gene transfected NCI-H460 lung cancer cell line with dendritic cells]. Zhang ZY; Wu JM Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):17-20. PubMed ID: 17575687 [TBL] [Abstract][Full Text] [Related]
2. [An experimental study on the antitumor effects induced by fusions of dendritic cells with NCI-H460 lung cancer cells]. Zhang ZY; Wu JM; Pan HM Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):152-5. PubMed ID: 16677473 [TBL] [Abstract][Full Text] [Related]
3. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT. Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991 [TBL] [Abstract][Full Text] [Related]
4. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
5. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]. Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells]. Chen J; Cao X; Xiu Q Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964 [TBL] [Abstract][Full Text] [Related]
7. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]. Tan G; Wang ZY; Yin S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530 [TBL] [Abstract][Full Text] [Related]
9. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice]. He DM; Zhang H Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747 [TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of fusion vaccine prepared by renal cell carcinoma 786-O cell line and peripheral blood dendritic cells of healthy volunteers in vitro and in human immune reconstituted SCID mice. Hu Z; Liu S; Mai X; Hu Z; Liu C Cell Immunol; 2010; 262(2):112-9. PubMed ID: 20167310 [TBL] [Abstract][Full Text] [Related]
12. [Primary study on fusions of ovarian carcinoma cells to dendritic cell transfected with interleukin-12 gene in vitro]. Peng P; Shen K; He W; Wu M; Wei W; Lang JH; Zhang SM; Qi J; Hu Y; Zhao JQ Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):57-61. PubMed ID: 16635331 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro. Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038 [TBL] [Abstract][Full Text] [Related]
14. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma]. Guo C; Liu QG; Yang W; Yao YM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039 [TBL] [Abstract][Full Text] [Related]
15. [Effects of IL-18 gene transfection on the proliferation in vitro and tumorigenesis in vivo of mouse ovarian cancer cell line OVHM]. Cui C; Hao SW; Li XW; Bai XJ; Cheng JX; Shan BE Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):577-80. PubMed ID: 18538088 [TBL] [Abstract][Full Text] [Related]
16. Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids. Ziske C; Etzrodt PE; Eliu AS; Gorschlüter M; Strehl J; Flieger D; Messmer D; Schmitz V; Gonzalez-Carmona MA; Sievers E; Brossart P; Sauerbruch T; Schmidt-Wolf IG Pancreas; 2009 Oct; 38(7):758-65. PubMed ID: 19546834 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 18 gene transfer expands the repertoire of antitumor Th1-type immunity elicited by dendritic cell-based vaccines in association with enhanced therapeutic efficacy. Tatsumi T; Gambotto A; Robbins PD; Storkus WJ Cancer Res; 2002 Oct; 62(20):5853-8. PubMed ID: 12384548 [TBL] [Abstract][Full Text] [Related]
18. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity. Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Miyagi T; Jinushi M; Sakamori R; Kohga K; Uemura A; Ohkawa K; Storkus WJ; Hayashi N Gene Ther; 2007 Jun; 14(11):863-71. PubMed ID: 17344900 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528 [TBL] [Abstract][Full Text] [Related]
20. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines. Liu Z; Fan H; Wu Y; Chen B Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]